The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022

Pub Date : 2024-03-20 DOI:10.1080/21678707.2024.2333245

Abraham Viju Ipe, Lewis J. Fermaglich, Selma Kraft, Catherine Mease, Tran Le, Kathleen L. Miller

引用次数: 0

Abstract

Rare cancers account for approximately 1 in 8 of all cancers diagnosed in the United States (US) every year. Remarkable scientific advances in cancer research over the past 40 years, in addition to...

查看原文

孤儿药法案》与罕见癌症：1983-2022 年肿瘤孤儿药指定及相关批准的回顾性分析

在美国每年确诊的所有癌症中，罕见癌症约占八分之一。在过去的 40 年中，癌症研究取得了显著的科学进步，此外...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文